Core Scientific (MIL:1CORZ) ROE %: 0.00% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MIL:1CORZ Core Scientific Inc MIL:1CORZ
36 GF Score
Price €18.76
GF Value €9.18
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Core Scientific ROE %?

Core Scientific MIL:1CORZ +12.91% 36 ROE % is 0.00% as of Jun. 2026. GuruFocus rates MIL:1CORZ with a GF Score™ of 36/100 and a GF Value™ of €9.18 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 2,690 Software companies, Core Scientific ranks worse than 37174.68% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Core Scientific's annualized net income for the quarter that ended in Jun. 2026 was €-4,011.2 Mil. Core Scientific's average Total Stockholders Equity over the quarter that ended in Jun. 2026 was €-1,614.7 Mil. Therefore, Core Scientific's annualized ROE % for the quarter that ended in Jun. 2026 was N/A%.

The historical rank and industry rank for Core Scientific's ROE % or its related term are showing as below:

During the past 7 years, Core Scientific's highest ROE % was 6.62%. The lowest was -460.65%. And the median was -11.85%.

MIL:1CORZ's ROE % is not ranked *
in the Software industry.
Industry Median: 4.79
* Ranked among companies with meaningful ROE % only.

Core Scientific  (MIL:1CORZ) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Jun. 2026 )
=Net Income/Total Stockholders Equity
=-4011.236/-1614.7095
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-4011.236 / 570.104)*(570.104 / 3609.3385)*(3609.3385 / -1614.7095)
=Net Margin %*Asset Turnover*Equity Multiplier
=-703.6 %*0.158*N/A
=ROA %*Equity Multiplier
=-111.17 %*N/A
=N/A %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Jun. 2026 )
=Net Income/Total Stockholders Equity
=-4011.236/-1614.7095
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-4011.236 / -4004.616) * (-4004.616 / -54.692) * (-54.692 / 570.104) * (570.104 / 3609.3385) * (3609.3385 / -1614.7095)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 1.0017 * 73.2212 * -9.59 % * 0.158 * N/A
=N/A %

Note: The net income data used here is four times the quarterly (Jun. 2026) net income data. The Revenue data used here is four times the quarterly (Jun. 2026) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Core Scientific ROE % Related Terms


Core Scientific ROE % Historical Data

* Premium members only.

The historical data trend for Core Scientific's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Core Scientific ROE % Chart

Core Scientific Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE %
Get a 7-Day Free Trial 6.64 -506.18 0.00 0.00 0.00

Core Scientific Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 Negative Equity 0.00 0.00

MIL:1CORZ vs DBX, MBGL, S: ROE % Comparison

For the Software - Infrastructure subindustry, Core Scientific's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Core Scientific ROE % vs Software Industry

For the Software industry and Technology sector, Core Scientific's ROE % distribution charts can be found below:

* The bar in red indicates where Core Scientific's ROE % falls into.


MIL:1CORZ
36GF Score
Core Scientific Inc MIL:1CORZ
ROE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Core Scientific ROE % Calculation

Core Scientific's annualized ROE % for the fiscal year that ended in Dec. 2025 is calculated as

ROE %=Net Income (A: Dec. 2025 )/( (Total Stockholders Equity (A: Dec. 2024 )+Total Stockholders Equity (A: Dec. 2025 ))/ count )
=-246.478/( (-900.612+-822.18)/ 2 )
=-246.478/-861.396
=N/A %

Core Scientific's annualized ROE % for the quarter that ended in Jun. 2026 is calculated as

ROE %=Net Income (Q: Jun. 2026 )/( (Total Stockholders Equity (Q: Mar. 2026 )+Total Stockholders Equity (Q: Jun. 2026 ))/ count )
=-4011.236/( (-1129.418+-2100.001)/ 2 )
=-4011.236/-1614.7095
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2026) net income data. ROE % is displayed in the 30-year financial page.

* Note that if the average Total Stockholders Equity is zero or negative, then ROE % would be considered meaningless and hence not be calculated.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.00% mean?
Core Scientific (MIL:1CORZ) has a ROE % of 0.00% as of Jun. 2026. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Core Scientific and its competitors. According to the industry distribution chart, Core Scientific ranks #999999 out of 2690 companies in the Software industry.
Is Core Scientific's ROE % too high?
Core Scientific's current ROE % is 0.00%. Based on the distribution chart, Core Scientific ranks #999999 out of 2690 companies in the Software industry, which is in the bottom quartile relative to peers. Overall, Core Scientific has a GF Score™ of 36/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Core Scientific's ROE % compare to DBX and MBGL?
According to the Software industry distribution chart, Core Scientific ranks #999999 out of 2690 companies for ROE %. This places Core Scientific in the lower half of its industry. The industry median ROE % is 4.79. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Software company?
The median ROE % among Software companies is 4.79, based on 2,690 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Core Scientific and its competitors. For the Software industry, the median ROE % is 4.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Core Scientific's current ROE % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Core Scientific stock overvalued right now?
Based on GuruFocus' analysis, Core Scientific (MIL:1CORZ) is currently considered Significantly Overvalued. The stock's GF Value™ is €9.18, compared to a current price of €18.76 — trading 104.3% above its estimated fair value. The current ROE % is 0.00%. Core Scientific's overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Core Scientific (MIL:1CORZ), the current ROE % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Core Scientific (MIL:1CORZ) Overvalued in 2026?

Based on GuruFocus' analysis, Core Scientific stock appears to be overvalued. The current stock price of €18.76 is trading 104.3% above its estimated GF Value™ of €9.18. GuruFocus considers Core Scientific to be Significantly Overvalued.

Key valuation signals for MIL:1CORZ:

  • ROE %: 0.00%
  • GF Value™: €9.18 vs. price of €18.76 (104.3% above fair value)
  • GF Score™: 36/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CORZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Core Scientific Business Description

Other Exchanges CORZ:USA7ZD:Germany
Address 838 Walker Road, Suite 21-2105, Dover, DE, USA, 19904
Core Scientific Inc is engaged in designing, building, and operating digital infrastructure for high-density colocation services and digital asset mining. The business operates in three operating segments: Digital Asset Self-Mining, consisting of performing digital asset mining for its own account, Digital Asset Hosted Mining, consisting of providing hosting services to third parties for digital asset mining, and Colocation, consisting of providing high-density colocation services to third parties for AI / HPC operations. The majority of revenue is derived from the Digital Asset Self-Mining Segment.
36GF Score

Get the complete analysis for MIL:1CORZ

ROE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€18.76
Price
€9.18
GF Value